PetMed Express (NASDAQ:PETS) Rating Lowered to “Hold” at StockNews.com

StockNews.com downgraded shares of PetMed Express (NASDAQ:PETS) from a buy rating to a hold rating in a research report sent to investors on Tuesday.

PetMed Express Trading Up 8.2 %

Shares of PETS opened at $4.47 on Tuesday. The company has a market cap of $92.35 million, a PE ratio of -74.50 and a beta of 0.70. The stock has a 50-day moving average price of $5.11 and a 200-day moving average price of $4.32. PetMed Express has a 12-month low of $2.90 and a 12-month high of $6.85.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. As a group, analysts predict that PetMed Express will post 0.24 earnings per share for the current year.

Insider Activity at PetMed Express

In related news, Director Leslie C.G. Campbell purchased 15,000 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were acquired at an average cost of $5.38 per share, with a total value of $80,700.00. Following the purchase, the director now directly owns 70,000 shares of the company’s stock, valued at approximately $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 1.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On PetMed Express

Large investors have recently bought and sold shares of the stock. R Squared Ltd purchased a new position in PetMed Express in the 4th quarter worth approximately $31,000. Virtu Financial LLC purchased a new position in PetMed Express in the 4th quarter worth approximately $58,000. Diametric Capital LP purchased a new position in shares of PetMed Express during the fourth quarter valued at approximately $86,000. Blair William & Co. IL increased its stake in shares of PetMed Express by 95.2% during the fourth quarter. Blair William & Co. IL now owns 20,300 shares of the company’s stock valued at $98,000 after buying an additional 9,900 shares during the period. Finally, Independent Advisor Alliance bought a new stake in shares of PetMed Express during the third quarter valued at approximately $106,000. 73.33% of the stock is owned by hedge funds and other institutional investors.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.